首頁
Eli Lilly and Company

11月 2025Eli Lilly and Company的市場佔有率分析

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

健康 > 生物技術和製藥

域名lilly.co.jp

成立年份1876

僱員> 10001

年度營收> $1B

Eli Lilly and Company

Eli Lilly and Company（包含公司地區）

lilly.co.jp

查看更多網站流量與參與度資訊

Eli Lilly and Company截至 11月 2025 的總收入為 > 1B

Eli Lilly and Company 熱門網域產生的總收入

Eli Lilly and Company 熱門網域 3 年內的總收入

Eli Lilly and Company 熱門網域的總收入

lilly.co.jp> 1B

透過銷售情報查看更多內容

11月 2025Eli Lilly and Company的股票價格

Eli Lilly and Company 股票交易代碼 #LLY。以下是截至 11月 2025Eli Lilly and Company 過去 12 個月的股票績效

Eli Lilly and Company的熱門網域總造訪量

了解Eli Lilly and Company市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Eli Lilly and Company的熱門網域平均造訪時長

分析Eli Lilly and Company參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Eli Lilly and Company的熱門網域平均頁面瀏覽量

了解Eli Lilly and Company如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Eli Lilly and Company按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

novonordisk.co.jp公司名Novo Nordisk僱員> 10001總部丹麥, Bagsvaerd年度營收> $1B訪問總量64.4K健康 > 生物技術和製藥

使用的熱門技術Eli Lilly and Company

这些是Eli Lilly and Company顶级域名使用的行业网站技术

行動裝置 (3)

Meta Viewport

付費廣告 (2)

DoubleClick

電子商務 (2)

USPS

音訊視訊媒體 (1)

Kaltura

更多技術

3

檢視所有

新聞與訊號來自Eli Lilly and Company

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Eli Lilly Japan K.K launches Mounjaro subcutaneous injection 2.5 mg / 5 mg ATEOS.Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation (MTPC) have announced the launch of Mounjaro subcutaneous injection 2.5 mg / 5 mg ATEOS in Japan.

新聞Eli Lilly Japan K.K partners with Daiichi Sankyo.Through this commercialisation collaboration with Daiichi Sankyo, which has a solid operating foundation in Japan based on its established position and global network in the fields of central nervous system diseases and pain management, Eli Lilly Japan will strengthen its system for providing healthcare professionals with proper information through both Emgality and lasmiditan succinate after obtaining marketing approval.

新聞Eli Lilly Japan K.K partnered with GlaxoSmithKline on Jan 31st '21.At the end of January, Vir’s shares surged more than 70 per cent to a record high after the announcement that drugs giant Eli Lilly would team up with Glaxo and Vir to test its Covid-19 antibody treatment.